Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
CARGO Therapeutics, Inc. | President & CEO, Director | Common Stock | 104K | $1.56M | $15.00 | Nov 9, 2023 | Direct |
CARGO Therapeutics, Inc. | President & CEO, Director | Stock Option (Right to Buy) | 400K | Mar 1, 2024 | Direct | ||
Entrada Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 16K | Jun 13, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TRDA | Entrada Therapeutics, Inc. | Jun 13, 2024 | 1 | $0 | 4 | Jun 14, 2024 | Director |
CRGX | CARGO Therapeutics, Inc. | Mar 1, 2024 | 1 | $0 | 4 | Mar 4, 2024 | President & CEO, Director |
CRGX | CARGO Therapeutics, Inc. | Nov 9, 2023 | 0 | $0 | 3 | Nov 9, 2023 | President & CEO, Director |
TRDA | Entrada Therapeutics, Inc. | Sep 1, 2023 | 1 | $0 | 4 | Sep 5, 2023 | Director |
TRDA | Entrada Therapeutics, Inc. | Sep 1, 2023 | 0 | $0 | 3 | Sep 5, 2023 | Director |